NESTcc Test-Case Insights from J&J, Lahey in Market Pathways

NESTcc Test-Case insights from Johnson & Johnson and Network Collaborator Lahey Hospital & Medical Center highlight the February issue of MedTech Strategist Market Pathways.

Johnson & Johnson has nearly completed a proactive post-market surveillance for safety and effectiveness of Class II lumbar interbody system device procedures. Real-World Evidence gathered from this and other NESTcc Test-Cases promises to open the door to new opportunities for device stakeholders to work together to share and leverage powerful real-world data—and shift the paradigm for how medtech innovates.

Read the article Real-World Evidence and Johnson & Johnson: NESTcc Unlocking Doors to Medical Device Innovation and Collaboration (subscription required).

Follow us @NESTccMedTech

NESTcc's Test-Case study protocol on synthetic mid-urethral slings for stress urinary incontinence in women is open for public comment through June 12. More: bit.ly/2RM654T pic.twitter.com/fk4ore1Kmg 1 day ago

NESTcc is requesting public comments on the study protocol of our Test-Case focused on synthetic mid-urethral slings for stress urinary incontinence in women. The comment period is open until June 12. More: bit.ly/2RM654T pic.twitter.com/5owFLFq1Fl 1 week ago

National Evaluation System for health Technology Coordinating Center (NESTcc)
1501 Wilson Blvd., Suite 910, Arlington, VA 22209

© Copyright 2020 | Privacy Policy

An Initiative of:

MDIC logo

Follow MDIC:

Twitter logo
LinkedIn Logo